PNC FINANCIAL SERVICES GROUP, INC.
Position in AVXL — Anavex Life Sciences Corp.
CIK 713676
Pittsburgh, PA
Position in AVXL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$190,622
-$36,103 QoQ
Shares Held
62,092
-2.5% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $99,745,787 across 265 Biotechnology names. AVXL ranks #52 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
71,942 | $32,124,978 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,226 | $14,082,131 | |
| 3 | TECH |
BIO-TECHNE Corp
|
93,722 | $4,897,909 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,322 | $4,076,976 | |
| 5 | MRNA |
Moderna, Inc.
|
69,883 | $3,550,054 | |
| 6 | INCY |
Incyte Corp
|
33,976 | $3,197,817 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
37,360 | $3,135,250 | |
| 8 | ARGX |
Argenx SE
|
3,796 | $2,772,027 |
All Filings in AVXL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $190,622 | 62,092 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $226,725 | 63,687 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $569,848 | 64,028 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $585,570 | 63,511 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $494,832 | 57,673 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $512,372 | 47,707 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $270,974 | 47,707 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $165,874 | 39,307 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $116,835 | 22,954 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $165,083 | 17,732 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $114,310 | 17,452 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $152,144 | 18,714 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $149,563 | 17,452 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $143,085 | 15,452 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $138,824 | 13,452 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $74,594 | 7,452 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $36,117 | 2,934 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $42,517 | 2,452 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $35,900 | 2,000 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $45,720 | 2,000 | Shares | Defined | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||